Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:EDGE

Edge Therapeutics (EDGE) Stock Price, News & Analysis

Edge Therapeutics logo

About Edge Therapeutics Stock (NASDAQ:EDGE)

Advanced Chart

Key Stats

Today's Range
$41.29
$41.29
50-Day Range
$0.50
$6.71
52-Week Range
$0.28
$17.38
Volume
15 shs
Average Volume
373,201 shs
Market Capitalization
$1.30 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EDGE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Edge Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

EDGE Stock News Headlines

Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
See More Headlines

EDGE Stock Analysis - Frequently Asked Questions

Edge Therapeutics, Inc. (NASDAQ:EDGE) announced its quarterly earnings results on Thursday, November, 1st. The biotechnology company reported ($0.11) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.16.

Based on aggregate information from My MarketBeat watchlists, some other companies that Edge Therapeutics investors own include ContraFect (CFRX), McEwen (MUX), Arena Pharmaceuticals (ARNA), BioLineRx (BLRX), Bristol Myers Squibb (BMY), Cerecor (CERC) and CRISPR Therapeutics (CRSP).

Company Calendar

Last Earnings
11/01/2018
Today
8/09/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:EDGE
CIK
1472091
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$40.86 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-81.29%
Return on Assets
-56.92%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.59
Quick Ratio
5.59

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.95 per share
Price / Book
43.46

Miscellaneous

Outstanding Shares
31,510,000
Free Float
N/A
Market Cap
$1.30 billion
Optionable
Not Optionable
Beta
3.65
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:EDGE) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners